/C O R R E C T I O N — The Galien Foundation/

In the news release, The Galien Foundation Announces 2025 Prix Galien USA Nominees for “Best Digital Health Solution,” “Best Medical Technology,” “Incubators, Accelerators and Equity,” and “Best Startup”, issued 13-Aug-2025 by The Galien Foundation over PR Newswire, we are advised by the company that a final sentence has been added with a link to the 3rd paragraph. Company name change to “Future Doctor Inc” to “Future Doctor Limited” and “Otsuka Precision Health” to “Otsuka Precision Health, Inc.” and a registar mark to “Rejoyn”. Dr. Mikael Dolsten title change to inlcude “Former”. The complete, corrected release follows:

The Galien Foundation Announces 2025 Prix Galien USA Nominees for “Best Digital Health Solution,” “Best Medical Technology,” “Incubators, Accelerators and Equity,” and “Best Startup”

The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2025 Prix Galien USA Award nominees for “Best Digital Health Solution,” “Best Medical Technology,” “Incubators, Accelerators and Equity,” and “Best Startup.” Winners will be announced during the Prix Galien USA Awards Ceremony on October 30, 2025, at the American Museum of Natural History in New York City.

https://mma.prnewswire.com/media/2749810/5458539/The_Galien_Foundation__logo.jpg

“As Jury Chair, I am honored to recognize these exceptional nominees who exemplify the transformative power of innovation in medical technology, digital health, and entrepreneurship,” said Kenneth C. Frazier, Chair of the Jury, Prix Galien USA Awards Committee. “Their groundbreaking work represents the future of healthcare and our shared commitment to improving lives through scientific excellence.”

The 2025 Prix Galien USA nominees include products from the following categories: “Best Digital Health Solution” – 25 nominees; “Best Medical Technology” – 25 nominees; “Best Incubators, Accelerators and Equity” – 12 nominees, and “Best Startup” – 53 nominees. To explore this year's nominees in all award categories, please click here.

To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for marketing within the last five years and demonstrate tremendous potential to improve human health. Sales data are not considered by the nominating committee in their award nominee selection, only science and health impact.

Best Digital Health Solution (Nominees)

Abbott NeuroSphere™ Virtual ClinicAdhereTech Aidia SystemAll4Cure, Inc. All4Cure Platform, MyelomaMap (TM), TrialMatchMMAptar Digital Health Migraine Buddy's Weather and Trigger Advanced ReportsBeaconcure VerifyCleerly Cleerly LABS Plaque AnalysisClinical ink GlucoseReady (TM)DNAnexus + Boehringer Project PRISM/Project CRYPTxIngelheim JointSubmissionEmpatica Empatica Health Monitoring PlatformEvinova Unified Trial SolutionFirst Ascent Biomedical Inc xDRIVE/DxPP – Ex Vivo Drug Response Identification & Validation Engine / Drug Prediction PlatformFuture Doctor Limited MedGPT – AI Digital Twin of DoctorsHelfie AI Helfie AIMPA MyPsychAdmin – The only AI solution that frees Mental Health Practitioners from computers/admin so they can spend more time with their patients.Mymee Mymee's product is a proprietary personalized trial & care platform for rheumatic autoimmune patients who can no longer control disease flares with prescription therapies.NeuraLight NeuraLight platformOtsuka Precision Health, Inc. Rejoyn®OURA Oura Ring 4Patientory, Inc. Patientory Digital Health Data WalletRapidAI Rapid AneurysmRecursion Recursion Operating System (OS): end-to-end AI-driven drug discovery and development platformTECHMEDO Inc. Healthcare Operating SystemUniversity of Rochester – Wilmot Cancer Institute University of Rochester – Wilmot Cancer Institute's HyperionWARD 24/7 WARD Clinical Support System (WARD-CSS)Wheel Wheel Horizon

Best Medical Technology (Nominees)

Abbott Esprit™ BTK Everolimus Eluting Resorbable Scaffold SystemAbbott AVEIR™ Dual Chamber (DR) Leadless Pacemaker SystemAbbott TriClip™ G4 SystemAlcon TOTAL30® Soft Contact LensesBeyond Air, Inc. LungFit® PHbioMérieux BIOFIRE® SPOTFIRE® System and BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) PanelBioProtect BioProtect Balloon SpacerBody Vision Medical LTD. LungVision®Boston Scientific FARAPULSE™ Pulsed Field Ablation SystemCresilon TRAUMAGEL®Edwards Lifesciences Edwards SAPIEN 3 Ultra RESILIA Transcatheter Aortic Heart ValveEdwards Lifesciences Edwards EVOQUE Transcatheter Tricuspid Valve Replacement SystemENDOLOGIX LLC DETOUR SystemEstablishment Labs Holdings Inc. Motiva Flora® SmoothSilk® Tissue ExpanderGuardant Health Guardant360® CDxImpulse Dynamics Optimizer® Smart Mini SystemMedtronic MiniMed™ 780G automated insulin delivery systemMedtronic Symplicity Spyral™ Renal Denervation SystemMedtronic Inceptiv™ SCSOUR United Corporation TaiChiPro®Perspectum CoverScanPolarean XENOVIEW HPX SystemRefleXion Medical RefleXion® X1 with SCINTIX® biology-guided radiotherapySmith & Nephew, Inc. CORI Surgical SystemTerumo Aortic Thoraflex Hybrid

Best Incubators, Accelerators and Equity (Nominees)

AVANT BIO AVANT BIO Fund II LPCalibr-Skaggs Institute for Innovative Medicines Calibr-Skaggs Drug AcceleratorCornell University Center for Life Science VenturesCross-Border Impact Ventures Women's and Children's Health Technology FundCube Labs Cube LabsEIT Health EIT Health AcceleratorEndless Frontier Labs Endless Frontier LabsMATTER SMILE HealthMayo Clinic Mayo Clinic and Arizona State University Alliance for Health Care AcceleratorMcGill Dobson Centre for Entrepreneurship McGill Dobson Centre for EntrepreneurshipNucleate The ActivatorOROT – CIUSSS West-Central Montreal OROT – Connected Health Incubator, CIUSSS West Central (Montréal)

Best Startup (Nominees)

Actipulse Neuroscience ActipulseAdaptilens, Inc.ADVANCED BIODESIGNALGA BIOLOGICS ALGA BIOLOGICSAscidian TherapeuticsBigHat Biosciences Milliner™Bitterroot BioBloqcube Inc.Canary Medical Canary MedicalClick Therapeutics Prescription Digital TherapeuticsCUTISS AGDren BioDuo Oncology Duo OncologyEsperto Medical, Inc.Ganymed Robotics Ganymed RoboticsGatehouse Bio, Inc.Geneos Therapeutics GNOS-PV02+INO-9012 followed by intradermal electroporation. Personalized Therapeutic Cancer VaccineGleamerHope MedicineImaginostics, Inc.Immunis, Inc.Insilico MedicineIntrepid LabsKapsule Kapsule TerminalLEAF4Life, Inc.Libera Bio S.L. MPN TechnologymagAssist Co., Ltd.Mammoth BiosciencesManus Neurodynamica NeuroMotor Pen™MediVIE TechMicron Biomedical, Inc.Navigation Sciences, Inc.Nona BiosciencesNospharmaParadigm TherapeuticsQubit Pharmaceuticals Qubit PharmaceuticalsQuercisREGEnLIFEResuscitec GmbHSEED Therapeutics Inc.Seismic TherapeuticSFA Therapeutics, Inc.Shenzhen ReeToo Biotechnology Co., Ltd.SIMEDYS SIMEDYSSmartBiotic Antimicrobial Management by SmartbioticStrand TherapeuticsSURGE TherapeuticsTargED Biopharmaceuticals B.V.Turbine Simulated Cell Technologies LimitedViCardia Therapeutics, Inc.Vocxi Health MyBreathPrintXaTek Inc. ClotChipZest Health Zest Health

Bruno Cohen, Chairman of The Galien Foundation, commented, “We are honored to recognize this year's outstanding Prix Galien USA nominees, whose innovation in medical technology, digital health, and entrepreneurship demonstrates the progress that moves healthcare forward. Their achievements reveal the extraordinary potential of science to change lives.”

Prix Galien Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup Committee 2025

Kenneth C. FRAZIERCommittee Chair, Former Chairman & CEO Merck

Roch DOLIVEUXHonorary CEO, UCB

Dr. Mikael DOLSTENFormer Chief Scientific Officer & President, Pfizer Research and Development

Alex GORSKYFormer CEO & Executive Chairman, Johnson & Johnson

Penny HEATONGlobal Therapeutic Area Head, Vaccines, Janssen

Sheri McCOYBoard of Directors, AstraZeneca, Former CEO, Avon

Joel S. MARCUSExecutive Chairman & Founder, Alexandria

Elias ZERHOUNIFormer Head of Global R&D, Sanofi

About The Galien Foundation The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives. The late Professor Elie Wiesel, 1986 Peace Nobel Laureate, is The Honorary Founding President of The Galien Foundation

The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries, Africa and an inaugural chapter established in India in 2024. The Prix Galien was created in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

For more information, visitwww.galienfoundation.org.

Follow the Foundation on social media: https://www.facebook.com/GalienFoundation/https://twitter.com/GalienFdnhttps://www.linkedin.com/company/the-galien-foundation/

Media Contact:Kara Bradley Finn Partners Kara.Bradley@finnpartners.com646-213-7243

https://c212.net/c/img/favicon.png?sn=NY50725A&sd=2025-08-27

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-galien-foundation-announces-2025-prix-galien-usa-nominees-for-best-digital-health-solution-best-medical-technology-incubators-accelerators-and-equity-and-best-startup-302529091.html

SOURCE The Galien Foundation

https://rt.newswire.ca/rt.gif?NewsItemId=NY50725&Transmission_Id=202508271528PR_NEWS_USPR_____NY50725A&DateId=20250827